bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • KalVista Pharmaceuticals Inc. logo

    KalVista Pharmaceuticals Inc.

    KALV | NASDAQ
    Chart Builder DCF Calculator
    $27
    $0 (0.00%)
    Jun 10, 2026, 4:00 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.44B
    Enterprise Value
    $1.42B
    Beta
    -0.29
    Average Volume
    3.42M
    Shares Outstanding (Diluted)
    50.54M
    Shares Change YoY
    1.78%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US4834971032

    Price Performance

    Price Change 1M
    0.9%
    Price Change 3M
    58.8%
    Price Change 6M
    70.5%
    Price Change YTD
    74.6%
    Price Change 1Y
    119.3%
    Price Change 3Y
    194.1%
    Price Change 5Y
    -3.4%
    1M CAGR (ann.)
    1.3%
    1Y CAGR (ann.)
    100.6%
    5Y CAGR (ann.)
    -0.8%
    All-Time CAGR
    -9.0%

    Valuation

    PE Ratio
    -8.36
    Forward PE
    107.23
    PEG Ratio
    -0.56
    Forward PEG
    0.05
    PS Ratio
    19.53
    Forward PS
    4.60
    PB Ratio
    -530.25
    P/FCF Ratio
    -17.25
    P/Adj. FCF Ratio
    -17.25
    P/OCF Ratio
    -24.32
    EV/Sales
    19.31
    EV/EBIT
    -8.27
    EV/EBITDA
    -8.34
    EV/FCF
    -17.06
    Earnings Yield
    -12.0%
    FCF Yield
    -5.8%
    Adj. FCF Yield
    -5.8%

    Financial Health

    Net Cash
    $26.73M
    Total Debt
    $284.21M
    Cash & Short-Term Investments
    $300.21M
    Total Assets
    $335.38M
    Current Ratio
    5.58
    Quick Ratio
    5.52
    Debt / Equity Ratio
    -104.83
    Debt / EBITDA
    -1.67
    Debt / FCF
    -3.41
    OCF / Debt
    -0.29
    Interest Coverage
    -6.22
    Altman Z-Score
    -1.16
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    92.0%
    Operating Profit Margin
    -233.4%
    EBITDA Margin
    -101.1%
    Net Profit Margin
    -119.4%
    FCF Margin
    -113.2%
    Adj. FCF Margin
    -113.2%
    SBC / Revenue
    4.6%
    SBC Impact (per share)
    N/A

    Returns

    Return on Assets
    -41.3%
    Return on Equity
    -1057.4%
    Return on Invested Capital
    -46.8%
    Return on Capital Employed
    -50.4%
    Return on Tangible Assets
    -41.3%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    150.0%
    Revenue CAGR 5Y
    100.0%
    Revenue CAGR 10Y
    119.0%
    EPS CAGR 3Y
    2.5%
    EPS CAGR 5Y
    -0.8%
    EPS CAGR 10Y
    -7.9%
    FCF CAGR 3Y
    2.8%
    FCF CAGR 5Y
    -8.8%
    FCF CAGR 10Y
    -22.2%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    13
    EPS Growth Next 3Y
    65.5%
    Revenue Growth Next 3Y
    91.0%
    Earnings Date
    Dec 2, 2026
    EPS Estimate (next Q)
    -$0.29
    EPS Growth Est (next Q)
    -68.0%
    Revenue Est (next Q)
    $48.66M
    Revenue Growth Est (next Q)
    255.4%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $27
    Price Target Upside
    0.0%

    Cash Flow

    Operating Cash Flow
    $-81.62M
    Free Cash Flow
    $-83.33M
    Adj. Free Cash Flow
    $-83.33M
    FCF Per Share
    -$1.12
    OCF Per Share
    -$1.11
    OCF/S Ratio
    -48.6%

    Income Statement

    Revenue
    $73.62M
    Gross Profit
    $67.54M
    Operating Income
    $-171.84M
    EBITDA
    $-170.39M
    Net Income
    $-164.29M
    EPS (Diluted)
    -$3.23
    Revenue / Employee
    $490.78K
    Profit / Employee
    $-1.1M
    Employees
    150

    © 2026 bestshares.com. All rights reserved.